AffyImmune Presents Preclinical Data on AIC100 Affinity-Tuned CAR T Targeting ICAM-1 in Additional Solid Tumor Types at AACR 2024
NATICK, Mass.--(BUSINESS WIRE)--Apr 9, 2024--
Source: eagletribune.com
Matt Britz News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Matt Britz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Matt Britz Today - Breaking & Trending Today
AffyImmune Therapeutics Awarded Best Oncology R&D Advance Scrip Award 2023
/PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid tumors, was...
Source: prnewswire.com
AffyImmune Therapeutics Adds Serial Entrepreneur Robert Forrester to Board of Directors
/PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company using its Tune & Track platform to develop CAR T cells for the treatment...
Source: prnewswire.com
AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior Vice President and Head of Clinical Development
/PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers,...
Source: prnewswire.com
AffyImmune Therapeutics to Present Poster at American Association for Cancer Research Annual Meeting
/PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company using its Tune & Track platform to develop CAR T cells for the treatment...
Source: prnewswire.com